Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05p -0.18% 28.05p 27.80p 28.30p 28.70p 27.50p 28.20p 154,242 16:35:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 105.15

Circassia Pharmaceuticals Share Discussion Threads

Showing 1051 to 1074 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
17/5/2019
14:17
Patience needed here, there are some big positions to unwind out of an illiquid stock imo dyor ofc.
rathean
16/5/2019
15:04
looks like this could be the start of a happy time, absolutely huge trades 10 million shares traded in 3 lots (possibly sells but not showing as such) and 10 million buys, this could well be our short closing, if so this is going to rise fast from here. Or just a share movement time will tell. Interesting that LSE has all 20 million trades down as buys, just can't see how that could be though as surely the price would have rocketed?
the abbot
16/5/2019
14:58
Look at today's volume. It is the highest intra-day volume since listing. Is the seller finally cleared?
mirabeau
15/5/2019
11:45
Not sure why you were ticked down for that post although could be jealousy, that is a bloody good buy, not sure though why the Directors do not also hold that opinion.
the abbot
13/5/2019
14:13
Just added at 26.67 although showing as a sell.
rathean
11/5/2019
15:58
Do CIr have any exposure to UK sales?
turvart
09/5/2019
09:29
We could ask them at the AGM For sure as this is a turnaround company since 2016, a director's purchase would quite possibly have a greater effect in halting the decline in the share price than most other interventions.
the abbot
09/5/2019
09:15
You would think that the directors might be interested at this level or is this just another milk it while it lasts jobbie
basem1
09/5/2019
08:59
Yes well there you go the shorter has control a whole string of AT trades to start the day, the issue here is the price is in their hands unless someone intervene and the company is unlikely to do that so its just a waiting game.
the abbot
09/5/2019
08:22
I did not buy many but my 10 percent stop loss has kicked in another Aim laggard
basem1
08/5/2019
19:21
The abbot, a lot of people have been bitten by aim stocks, myself included but I do like the sound of CIR, I will add some more in the near future funds permitting but I’m not going to get silly about it. Trouble is when these sort of stocks come good, then you have to live with the regret of not buying more. One thing I will vouch, I will buy more without getting silly and I’m holding to either it gets taken over or until I retire in 12 years, so I think 12 years is being patient 😀.
turvart
08/5/2019
16:24
Well I have to say that is a dissapointing day, not sure what is going on here, great results, 2 FDA approvals and today's RNS and price goes down, seems to me to be all in the control of the shorter - perhaps it would help for the directors to show a little faith and put their hands in their pockets - afterall it doesn't say too much when the shareprice has fallen 90% since float and they have yet to purchase a share!
the abbot
08/5/2019
10:14
Joined you for a few here abbot, just a toe in the water at the moment.
farmscan
08/5/2019
09:20
Proactive coverage, all good news of course; link blocked - just type circassia proactive in google Nice to see now being promoted in China hTTps://med.sina.com/article_detail_103_2_65484.html
the abbot
08/5/2019
08:49
Today - Peel Hunt reiterates it BUY rating with a target at 90p. hTTps://www.ybs.co.uk/sharedealing/company/index.html?company=CIR#view=broker-views
the abbot
08/5/2019
08:30
RNS OUT Wow my head spins when I think of the market share Circassia could take with this drug, a FULL publication is a major thing in the JAMA - this has huge coverage, quite simply it is Medicine. hTTps://investegate.co.uk/circassia-pharma-plc--cir-/rns/publication-of-tudorza-phase-iv-ascent-in-jama/201905080700032865Y/ Circassia Announces Publication of Tudorza® Phase IV ASCENT Study in the Journal of the American Medical Association Oxford, UK - 8 May 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces the full publication of the Tudorza® phase IV ASCENT study in the prestigious Journal of the American Medical Association*. The ASCENT study was conducted in patients with moderate-to-very severe chronic obstructive pulmonary disease (COPD) and cardiovascular disease and / or significant cardiovascular risk factors. This patient population is of particular relevance as cardiovascular disease is the most common and significant comorbidity of COPD, with approximately 30% of COPD patients dying from cardiovascular conditions. The ASCENT results demonstrate Tudorza® is effective at reducing COPD exacerbations with no increase in major cardiovascular events, and at reducing hospitalisations due to COPD exacerbations, in this at-risk population. At the end of March 2019, the FDA approved a supplemental New Drug Application (sNDA) adding these clinical data to Tudorza®'s prescribing information. As a result, Tudorza® is the only long-acting muscarinic antagonist (LAMA) in the United States with COPD exacerbation reduction data and data demonstrating cardiovascular safety in patients with cardiovascular disease / risk factors in its label. Steve Harris, Circassia's CEO, said: "The publication of these clinical results in the prestigious Journal of the American Medical Association further demonstrates Tudorza®'s safety and efficacy, particularly in this group of at-risk patients. We are delighted at this recognition of the importance of these data, and of the recent inclusion of this new information in Tudorza®'s prescribing information."
the abbot
07/5/2019
15:53
Shorters will keep a lid on it as they close out, share price firmly in sideways range now until shorters closed or next rns imo dyor ofc.
rathean
07/5/2019
15:46
wow the price just dipped, can't believe anyone would sell at this price thus the shorters have do control.
the abbot
07/5/2019
12:09
The abott Cheers for updates. In work so appreciate you keeping us informed.
neilyb675
07/5/2019
08:23
Turvart, I don't think we are going to need too much patience to see a correction in the price. I have a strong feeling we are starting to see the beginning of the shorts closing now - lets see how well they control the price. They may well be able to close without causing a large increase as they have so many shares they are in control, however they will based on market rules have to declare any change in the short position and that will send the signal to the market of what we already know, the fall has been overdone, it's at the bottom, the shorter knows it and the turnaround is beginning. For those that are technically focussed the 14 days of flat trading and the large doji gives the game away. Onwards and Upwards GLA EDIT: 50K trades back, are these the shorts closing, will continue for a while is my guess, with a percentage point or two here and there before final closing - definately at the bottom though so a great time to enter, hard for long term holders I know but always the opportunity to lower that overall average.
the abbot
03/5/2019
18:18
Patience is a virtue, this is not a traders stock, it’s for the long term investor, like I said it’s in my pension portfolio and I’ll add more over the coming weeks, months, unfortunately because I’m buying when I get paid I can only buy small amounts and have the commission against me. Has anyone spent anytime on a future forecast of what this stock could be potentially worth in 5/10 years time (If it doesn’t get taken over) I know nobody can predict anything accurately, but what’s the feeling where this could actually go?
turvart
03/5/2019
10:46
Yes, over a million shares traded already
the abbot
03/5/2019
09:38
Lots of chunky buys this morning....
neilyb675
03/5/2019
09:34
If people have not done so I would suggest a refresh of the latest RNS for AirNovent hTtps://investegate.co.uk/circassia-pharma-plc--cir-/rns/successful-fda-presubmission-meeting-for-airnovent/201902040806239121O/ This could be quite exciting and if approved, which is likely and is a long way along the pipeline already, the potential is good. The product seems far advanced compared to the competition, I would think this could take a very large market share. Circassia has a great pipeline chart and commercialisation summary here. hTtps://www.circassia.com/pipeline/commercial-opportunity/
the abbot
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190519 23:25:34